Climb Bio, Inc. (CLYM)
10.36
-0.51
(-4.69%)
USD |
NASDAQ |
Nov 13, 16:00
10.36
0.00 (0.00%)
After-Hours: 19:59
Climb Bio Market Cap : 598.06M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 598.06M |
| November 12, 2026 | 627.51M |
| November 11, 2026 | 707.17M |
| November 10, 2026 | 677.73M |
| November 09, 2026 | 635.59M |
| November 06, 2026 | 594.02M |
| November 05, 2026 | 512.05M |
| November 04, 2026 | 538.60M |
| November 03, 2026 | 562.85M |
| November 02, 2026 | 559.43M |
| October 30, 2026 | 588.72M |
| October 29, 2026 | 593.32M |
| October 28, 2026 | 581.26M |
| October 27, 2026 | 549.67M |
| October 26, 2026 | 506.01M |
| October 23, 2026 | 585.28M |
| October 22, 2026 | 605.38M |
| October 21, 2026 | 624.33M |
| October 20, 2026 | 620.31M |
| October 19, 2026 | 558.86M |
| October 16, 2026 | 564.02M |
| October 15, 2026 | 626.63M |
| October 14, 2026 | 591.02M |
| October 13, 2026 | 592.17M |
| October 12, 2026 | 622.04M |
| Date | Value |
|---|---|
| October 09, 2026 | 631.80M |
| October 08, 2026 | 623.76M |
| October 07, 2026 | 615.14M |
| October 06, 2026 | 613.42M |
| October 05, 2026 | 634.67M |
| October 02, 2026 | 628.35M |
| October 01, 2026 | 635.82M |
| September 30, 2026 | 658.79M |
| September 29, 2026 | 660.52M |
| September 28, 2026 | 674.30M |
| September 25, 2026 | 669.71M |
| September 24, 2026 | 682.92M |
| September 23, 2026 | 719.10M |
| September 22, 2026 | 816.17M |
| September 21, 2026 | 783.43M |
| September 18, 2026 | 806.98M |
| September 17, 2026 | 807.55M |
| September 16, 2026 | 810.43M |
| September 15, 2026 | 798.94M |
| September 14, 2026 | 836.27M |
| September 11, 2026 | 818.47M |
| September 10, 2026 | 858.67M |
| September 09, 2026 | 864.42M |
| September 08, 2026 | 913.24M |
| September 04, 2026 | 891.41M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Korsana Biosciences, Inc. | 1.441B |
| Cullinan Therapeutics, Inc. | 668.84M |
| Q32 Bio, Inc. | 260.36M |
| Oncolytics Biotech, Inc. | 46.12M |
| Sangamo Therapeutics, Inc. | 48.47M |
Market Cap Related Metrics
| PEG Ratio | -1.360 |
| Price to Book Value | 2.622 |
| Price | 10.36 |
| Earnings Yield | -7.92% |
| PEGY Ratio | -1.360 |